Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114375290A details scalable routes for Factor XIa inhibitor intermediates. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical production.
Patent CN101248037A reveals organocatalytic kinetic resolution for beta-amino acids, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN1597970A details microbial resolution for high-purity chiral intermediates. Offers cost-effective supply chain solutions for pharma and liquid crystal manufacturing.
Novel chiral resolution method for S-pantoprazole sodium ensures high purity and scalable production. Ideal for pharmaceutical intermediates supply chain optimization and cost efficiency.
Patent CN107383017B reveals a novel Ibrutinib synthesis route. Discover cost reduction in API manufacturing and enhanced supply chain reliability for Btk inhibitors.
Advanced patent CN101928301B details a novel configuration inversion method for levofosfomycin production, offering significant cost reduction and high purity for pharmaceutical manufacturers.
Advanced racemization recovery for Vernakalant intermediates using phosphine reagents. Enhances yield and reduces waste for reliable pharmaceutical intermediate supply chains.
Novel 5-step route for Ozanimod intermediates reduces cost and improves safety. Ideal for API intermediates manufacturing and supply chain optimization.
Patent CN101203614A reveals a novel EDTA-complexed enzymatic resolution for high-purity S-escitalopram, offering scalable cost reduction in API manufacturing.
Patent CN1322711A details a novel resolution method for Chloramphenicol. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.
Advanced chiral resolution for pyridoindole derivatives offering high optical purity. Discover cost-effective manufacturing and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN105622557B reveals a novel one-pot hydrogenation method for Ramelteon intermediates, offering high purity and significant supply chain cost advantages.
Advanced patent-based synthesis of cis,cis-3,5-dimethyl-1-cyclohexanol offering high chiral purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN1782088A details enzymatic resolution for high-purity tryptophan 15N. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalysis.
Patent CN104805148A details a novel enzymatic route for (1R,2S)-N-pyrrolidyl norephedrine. This method eliminates controlled precursors, offering significant cost and supply chain advantages for API manufacturers.
Novel nickel chelate synthesis enhances Maraviroc intermediate purity and yield while reducing environmental waste for reliable pharmaceutical supply chains.
Novel resolution method using lysine reduces costs and improves purity for glufosinate production. Reliable supply chain for herbicide intermediates.
Patent CN105712901B reveals a cost-effective enzymatic route for Hepatitis C intermediates. Discover scalable manufacturing and supply chain advantages.
Patent CN112724129A details a novel chiral purification method for moxifloxacin intermediates, offering superior ee values and scalable industrial production for reliable supply chains.
Patent CN101910101A reveals a novel aliphatic hydrocarbon recrystallization method boosting optical purity to >99% ee for pharmaceutical intermediates efficiently.